drugset / Trial / NCT04948164
Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks
Phase 3
Unknown
240 enrolled
Peking University Third Hospital
Beijing Friendship Hospital · collabJiangsu Provincial People's Hospital · collabSecond Affiliated Hospital of Wenzhou Medical University · collabSecond Hospital of Jilin University · collabThe Affiliated Hospital of Qingdao University · collabThe First Affiliated Hospital of Guangzhou Medical University · collabThe Second Affiliated Hospital of Kunming Medical University · collabThe Second Hospital of Nanjing Medical University · collabThe Third Xiangya Hospital of Central South University · collabWest China Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
A multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of sumatriptan naproxen sodium succinate tablets in the treatment of acute migraine attacks.
Timeline
- Start
- 2018-08-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naproxen | Small molecule | 500 mg | — |
| Subject | Sumatriptan | Unknown | 85 mg | — |